SEARCH

Sun, 11 Jan 2015 23:17 PM

A government health worker takes a blood sample from a woman to be tested for malaria in Ta Gay Laung village hall in Hpa-An district in Kayin state, south-eastern Myanmar, November 28, 2014. Malaria death rates dropped by 47 percent between 2000 and 2014 worldwide but it still killed some 584,000 people in 2013, most of them in sub-Saharan Africa, according to the World Health Organization (WHO). Much of the success in fighting the disease is due to the use of combination therapies (ACTs) based on artemisinin, a Chinese herb derivative, which is now under threat as malaria parasites have been building up resistance to the drugs. Experts say Myanmar, which has the largest malaria burden in the region, is the next frontier in the spread of resistance to artemisinin. Picture taken November 28, 2014. To match Feature HEALTH-MYANMAR/MALARIA THOMSON REUTERS FOUNDATION/Astrid Zweynert (MYANMAR - Tags: HEALTH POLITICS SOCIETY)

Sun, 11 Jan 2015 23:21 PM

Malaria tests are seen on a table in the Ta Gay Laung village hall in Hpa-An district in Kayin state, south-eastern Myanmar, November 28, 2014. Malaria death rates dropped by 47 percent between 2000 and 2014 worldwide but it still killed some 584,000 people in 2013, most of them in sub-Saharan Africa, according to the World Health Organization (WHO). Much of the success in fighting the disease is due to the use of combination therapies (ACTs) based on artemisinin, a Chinese herb derivative, which is now under threat as malaria parasites have been building up resistance to the drugs. Experts say Myanmar, which has the largest malaria burden in the region, is the next frontier in the spread of resistance to artemisinin. Picture taken November 28, 2014. To match Feature HEALTH-MYANMAR/MALARIA THOMSON REUTERS FOUNDATION/Astrid Zweynert (MYANMAR - Tags: HEALTH POLITICS SOCIETY)

Sun, 11 Jan 2015 23:20 PM

Villagers are tested for malaria in Ta Gay Laung village in Hpa-An district in Kayin state, south-eastern Myanmar, November 28, 2014. Malaria death rates dropped by 47 percent between 2000 and 2014 worldwide but it still killed some 584,000 people in 2013, most of them in sub-Saharan Africa, according to the World Health Organization (WHO). Much of the success in fighting the disease is due to the use of combination therapies (ACTs) based on artemisinin, a Chinese herb derivative, which is now under threat as malaria parasites have been building up resistance to the drugs. Experts say Myanmar, which has the largest malaria burden in the region, is the next frontier in the spread of resistance to artemisinin. Picture taken November 28, 2014. To match Feature HEALTH-MYANMAR/MALARIA THOMSON REUTERS FOUNDATION/Astrid Zweynert (MYANMAR - Tags: HEALTH POLITICS SOCIETY)

Tue, 16 Dec 2014 10:32 AM

In 2013, a Thai court ordered a cleanup, but government has yet to follow through

Tue, 16 Dec 2014 10:46 AM

Taliban say suicide bombers have entered the school, in revenge attack for anti-Taliban military offensive that began in June

Thu, 18 Dec 2014 23:13 PM

Myanmar is key to stopping the spread of drug-resistant malaria to India and Africa

Tue, 16 Dec 2014 08:48 AM

Military fighting FARC despite peace talks ongoing between rebel group and Cuba government in attempt to bring an end to 50 years of war

Tue, 16 Dec 2014 01:26 AM